[1] Takahashi T,Saikawa Y,Kitagawa Y.Gastric cancer:current status of diagnosis and treatment[J].Cancers(Basel),2013,5(1):48-63.
[2] Kikuchi R,Abe Y,Iijima K,et al.Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer[J].Tohoku J Exp Med,2011,223(1):35-44.
[3] Hosseini M,Amoueian S,Attaranzadeh A,et al.Serum gastrin 17,pepsinogen Ⅰ and pepsinogen Ⅱ in atrophic gastritis patients living in North-East of Iran[J].J Res Med Sci,2013,18(3):225-229.
[4] Shafaghi A,Mansour-Ghanaei F,Joukar F,et al.Serum gastrin and the pepsinogen Ⅰ/Ⅱ ratio as markers for diagnosis of premalignant gastric lesions[J].Asian Pac J Cancer Prev,2013,14(6):3931-3936.
[5] Sun LP,Gong YH,Wang L,et al.Serum pepsinogen levels and their influencing factors:a population-based study in 6 990 Chinese from North China[J].World J Gastroenterol,2007,13(48):6562-6567.
[6] 曹雪源,贾志芳,马洪喜,等.血清抗幽门螺杆菌抗体、胃蛋白酶原水平与胃癌发病的相关性分析[J].中国实验诊断学,2012,16(6):1026-1028.
[7] 毛秋卉,刘文佳,张学俭,等.血清胃蛋白酶原和胃泌素-17在胃癌筛选中的作用[J].国际消化病杂志,2012,32(2):85-87.
[8] 中华医学会消化病学分会.中国慢性胃炎共识意见[J].中华消化杂志,2013,33(1):5-16.
[9] Dixon MF,Genta RM,Yardley JH,et al.Classification and grading of gastritis.The updated Sydney System.International Workshop on the Histo-Pathology of Gastritis,Houston 1994[J].Am J Surg Pathol,1996,20(10):1161-1181.[10] Correa P.Human gastric carcinogenesis:Multistep and multifactorial process[J].CancerRes,1992,52(24):6735-6742.
[10] He CY,Sun LP,Gong YH,et al.Serum pepsinogen Ⅱ:a neglected but useful biomarker to differentiate between diseased and normal stomachs[J].J Gastroenterol Hepatol,2011,26(6):1039-1046.
[11] 陈智周,范振符.胃蛋白酶原Ⅰ、Ⅱ在早期胃癌普查中的意义[J].中华肿瘤杂志,2002,24(1):1-3.
[12] Fock KM,Talley N,Moayyedi P,et al.Asia-Pacific Gastric Cancer Consensus Conference.Asia-Pacific consensus guidelines on gastric cancer prevention[J].J Gastroenterol Hepatol,2008,23(3):351-365.
[13] Copps J,Murphy RF,Lovas S.The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers[J].Protein Pept Lett,2009,16(12):1504-1518.
[14] 曹勤,冉志华,萧树东.检测血清胃蛋白酶原和胃泌素-17诊断胃癌的临床价值[J].胃肠病学和肝病学杂志,2007,16(4):361-364.
[15] Sipponen P,Ranta P,Helske T,et al.Serum levels of amidated gastrin-17 and pepsinogen Ⅰ in atrophic gastritis:an observational case-control study[J].Scand J Gastroenterol,2002,37(7):785-791.
[16] 马颖杰,王惠吉,鲍晓厉.血清胃蛋白酶原与胃溃疡及胃癌[J].中国医刊,2008,43(12):46-48.